Showing results (231-240 of 472) with videos related to

Sort By:
Pageof 48
Therapeutic Advances in Cardiovascular Disease|June 28, 2015
The systemic vascular resistance response: a cardiovascular response modulating blood viscosity with implications for primary hypertension and certain anemiasGregory D Sloop, Joseph J Weidman, John A St Cyr
Therapeutic Advances in Cardiovascular Disease|June 28, 2015
Spironolactone is secure and reduces left ventricular hypertrophy in hemodialysis patientsGreicy Mara Mengue Feniman-De-Stefano, Silméia Garcia Zanati-Basan, Laercio Martins De Stefano, et al.
Therapeutic Advances in Cardiovascular Disease|June 18, 2015
Modulation of cardiac L-type Ca2+ current by angiotensin-(1-7): normal versus heart failurePeng Zhou, Che Ping Cheng, Tiankai Li, et al.
Therapeutic Advances in Cardiovascular Disease|March 17, 2018
Polypill: an affordable strategy for cardiovascular disease prevention in low-medium-income countriesPatricio López-Jaramillo, Silvia González-Gómez, Diego Zarate-Bernal, et al.
Therapeutic Advances in Cardiovascular Disease|February 13, 2018
Patency of the arterial pedal-plantar arch in patients with chronic kidney disease or diabetes mellitusAxel Haine, Alan G Haynes, Andreas Limacher, et al.
Therapeutic Advances in Cardiovascular Disease|May 25, 2016
Nitric oxide in paediatric respiratory disorders: novel interventions to address associated vascular phenomena?Farhana Akter, Gerry Coghlan, Achala de Mel
Therapeutic Advances in Cardiovascular Disease|May 28, 2020
Exercise therapy in routine management of peripheral arterial disease and intermittent claudication: a scoping reviewUkachukwu O Abaraogu, Onyinyechukwu D Abaraogu, Philippa M Dall, et al.
Therapeutic Advances in Cardiovascular Disease|June 26, 2020
Current status of white coat hypertension: where are we?Gani Nuredini, Alec Saunders, Chakravarthi Rajkumar, et al.
Therapeutic Advances in Cardiovascular Disease|May 23, 2020
Endovascular approach for acute limb ischemia without thrombolytic therapyKeisuke Fukuda, Yoshiaki Yokoi
Therapeutic Advances in Cardiovascular Disease|May 26, 2020
Antithrombotic and hemostatic stewardship: evaluation of clinical outcomes and adverse events of recombinant factor VIIa (Novoseven®) utilization at a large academic medical centerKassandra Marsh, David Green, Veronica Raco, et al.
Pageof 48